EODData

FRA, 135A: SCYNEXIS Inc

29 Jun 2026
LAST:

4.500

CHANGE:
 0.00
OPEN:
4.500
HIGH:
4.500
ASK:
0.000
VOLUME:
0
CHG(%):
0.00
PREV:
4.500
LOW:
4.500
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
29 Jun 264.5004.5004.5004.5000
25 Jun 264.5004.5004.5004.5000
23 Jun 264.5004.5004.5004.5000
22 Jun 264.5004.5004.5004.5000
19 Jun 264.5004.5004.5004.5000
17 Jun 264.5004.5004.5004.5000

PROFILE

Name:SCYNEXIS Inc
About:SCYNEXIS, Inc., a biotechnology company, develops medicines to overcome and prevent difficult-to-treat and drug-resistant infections in the United States. It offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis (VVC) and recurrent VVC. The company's lead product candidate is Ibrexafungerp, a drug for the treatment of invasive candidiasis and/or candidemia, refractory invasive fungal infections, invasive aspergillosis, VVC, and recurrent VVC. It also develops SCY-247 to treat systemic fungal diseases. The company has licensing and collaboration agreements with GlaxoSmithKline Intellectual Property (No. 3) Limited, Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, CJSC (R-Pharm), and Cypralis Limited for the development, manufacture, and commercialization of ibrexafungerp. SCYNEXIS, Inc. was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. The company was incorporated in 1999 and is headquartered in Jersey City, New Jersey.
Sector:Healthcare
Address:1 Evertrust Plaza, Jersey City, NJ, United States, 07302-6548
Website:https://www.scynexis.com
ISIN:US8112922005

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:0.89 
Forward P/E:-0.37 
PEG Ratio:0.00 
Price to Sales:0.30 
Price to Book:1.06 
Profit Margin:-1.21 
Operating Margin:-1.20 
Return on Assets:-0.21 
Return on Equity:-0.53 
Revenue:17.84M 
Shares:41.92M 
Market Cap:188.66M 

TECHNICAL INDICATORS

MA5:4.500.0%
MA10:4.500.0%
MA20:2.5476.9%
MA50:1.50199.9%
MA100:1.08315.2%
MA200:0.86422.0%
STO14:100.00 
RSI14:99.38 
MTM14:3.91
ROC14:6.63 
ATR:0.29 
Week High:4.500.0%
Week Low:4.500.0%
Month High:4.500.0%
Month Low:0.61422.0%
Year High:4.500.0%
Year Low:0.48842.4%

RECENT SPLITS

Date Ratio
01 Jun 20261-8
17 Jul 20201-10